Generate Biomedicines, Inc. (GENB)
Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
15. 79
+0.52
+3.4054%
After Hours
$
+0.21 +1.33% 16. 00
2.61B Market Cap
- P/E Ratio
- Div Yield
1.04M Volume
- Eps
$ 15.27
Previous Close 
Want to track GENB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Generate Biomedicines, Inc. (GENB) Statistics
Valuation metrics
Market Cap 2.61B
Enterprise value 1.89B
Trailing P/E (ttm) -14.46
Forward P/E -
PEG ratio -0.14
Price/Sales (ttm) 145.16
Price/Book (mrq) 4.31
Enterprise Value/Revenue 139.79
Enterprise Value/EBITDA -15.18
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.35M
Average volume (90 days) 1.69M
Price summary
52-Week low 11
52-Week high 22.67
Beta -
50-Day moving average 15.7
200-Day moving average 13.27
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -9.51%
Operating margin -10.03%
Operational effectiveness
Return on assets -0.23%
Return on equity -0.27%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.11
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.57
Total debt (mrq) -
Total Debt/Equity (mrq) 0.14
Current ratio (mrq) 8.3%
Book value per share (mrq) 3.56
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
